Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

ACT Latanoprost/Timolol

Covered
  • Active ingredient(s):
  • Manufactured by:
    Actavis Pharma Company (ActavisPhm)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2436256

GD-Latanoprost/Timolol

Covered
  • Active ingredient(s):
  • Manufactured by:
    Upjohn Canada SRI (Upjohn)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2373068

Jamp-Latanoprost/Timolol

Covered
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2453770

Med-Latanoprost-Timolol

Covered
  • Active ingredient(s):
  • Manufactured by:
    Generic Medical Partners Inc. (GMP)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2454505

M-Latanoprost-Timolol

Covered
  • Active ingredient(s):
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2514516

Latanoprost and timolol ophthalmic solution

Covered
  • Active ingredient(s):
  • Manufactured by:
    Hikma Canada Limited (Hikma)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2489368

Xalacom

Covered
  • Active ingredient(s):
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Ophtalmic Solution 0.005 % - 0.5 % DIN : 2246619

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.